Minster Pharmaceuticals Plc - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Minster Pharmaceuticals Plc. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Minster Pharmaceuticals Plc. The Group's principal activity is developing and selling drugs specialising in compounds for the treatment of neurological and psychiatric conditions. Products include Tonabersat and Sabcomeline. Tonabersat are neuronal gap junction blockers, which have significant potential in the prevention of migraine and probably also in other neurological indications. Sabcomeline, a muscarinic receptor partial agonist, has potential in the treatment of chronic schizophrenia.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report